ArticleBMC cancer2022

KAZN as a diagnostic marker in ovarian cancer: a comprehensive analysis based on microarray, mRNA-sequencing, and methylation data.

Songling Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.